The National Journal By Sophie Quinton Widespread vaccination against cervical cancer could reduce the need for burdensome screenings, U.S. and Finnish researchers said on Tuesday. A study published in the journal Lancet Oncology show that GlaxoSmithKline’s Cervarix vaccine, which protects against two strains of human papillomavirus, or HPV, was more than 93 percent effective in [...]
Continue reading...Friday, August 26, 2011
Source: The Associated Press Author: Staff Only about half of the teenage girls in the U.S. have rolled up their sleeves for a controversial vaccine against cervical cancer — a rate well below those for two other vaccinations aimed at adolescents. The vaccine hit the market in 2006. By last year, just 49 percent [...]
Continue reading...Saturday, June 25, 2011
Source: children.webmd.com Author: Daniel J. DeNoon, WebMD Health News (Reviewed by Louise Chang, MD) HPV (human papillomavirus) vaccines protect against the sexually transmitted strains of HPV that cause cervical cancer. The same HPV strains — spread by kissing and by oral sex — cause oropharyngeal (OP) cancer, the form of head and neck cancer that [...]
Continue reading...Tuesday, May 31, 2011
Source: blogs.wsj.com/health Author: Laura Landro A form of head and neck cancer associated with the sexually transmitted human papillomavirus is on the rise, especially in men, the WSJ reports. Fast-rising rates of oropharyngeal cancer — tumors in the tonsil and back-of-the-tongue area — have been linked to changes in sexual behavior that include the increased [...]
Continue reading...Saturday, March 12, 2011
Source: The Lancet, Volume 377, Issue 9769, Pages 881 – 883, 12 March 2011 Authors: Anna Giuliano et al. In The Lancet, Anna Giuliano and colleagues1 present a prospective study (HPV in Men [HIM]) of the incidence and clearance of human papillomavirus (HPV) infections in men. They also report on male sexual behavior, which determines [...]
Continue reading...Thursday, March 10, 2011
Corresponding author: Ahmedin Jemal, DVM, PhD, Surveillance Research, American Cancer Society The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and [...]
Continue reading...Thursday, February 10, 2011
Source: Star Observer The Pharmaceutical Benefits Advisory Committee (PBAC) will determine if the human papillomavirus (HPV) vaccine, Gardasil, should be included in the National Immunisation Program for boys. Gardasil is currently administered to girls when they begin high school to prevent cervical cancer. HPV, however, also causes throat cancer, genital and anal warts, and cancer [...]
Continue reading...Sunday, November 28, 2010
Source: www.dentalhealth.org.uk Author: press release An overwhelming majority of people in the UK have indicated that they want the vaccination for the Human Papilloma Virus (HPV) to include boys and not just girls. In a survey carried out by the British Dental Health Foundation as part of November’s Mouth Cancer Action Month, nine out of [...]
Continue reading...Sunday, November 14, 2010
Source: www.huffingtonpost.com Author: Leigh Vinocur, M.D. It is probably one of the most significant medical breakthroughs of this past decade. A vaccine to prevent cancer! We now better understand the link between cancers and viruses and how some viruses such as the human papillomavirus (HPV) can change cells and cause them to become cancerous. In [...]
Continue reading...Monday, November 8, 2010
Source: PubMed.gov Besides cervical cancer, the human papillomavirus (HPV) is found in other cancers and may be preventable with HPV vaccination. However, these other cancers are often not accounted for in cost-effectiveness analyses of HPV vaccination. This study estimates the potential maximum effect on the cost-effectiveness ratio (CER) of HPV vaccination in preventing non-cervical HPV-positive [...]
Continue reading...
Tuesday, November 8, 2011
0 Comments